DE1934272A1 - d-18-Methyl-17 alpha-alkinyl-4-oestren-17 beta-ole - Google Patents

d-18-Methyl-17 alpha-alkinyl-4-oestren-17 beta-ole

Info

Publication number
DE1934272A1
DE1934272A1 DE19691934272 DE1934272A DE1934272A1 DE 1934272 A1 DE1934272 A1 DE 1934272A1 DE 19691934272 DE19691934272 DE 19691934272 DE 1934272 A DE1934272 A DE 1934272A DE 1934272 A1 DE1934272 A1 DE 1934272A1
Authority
DE
Germany
Prior art keywords
methyl
acid
estren
hydrogen atom
schering
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
DE19691934272
Other languages
German (de)
English (en)
Inventor
Steinbeck Dr Hermann
Prezewowsky Dr Klaus
Schulze Dr Paul-Eberhard
Wiechert Dr Rudolf
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bayer Pharma AG
Original Assignee
Schering AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering AG filed Critical Schering AG
Priority to DE19691934272 priority Critical patent/DE1934272A1/de
Priority to ZA703801A priority patent/ZA703801B/xx
Priority to AU16466/70A priority patent/AU1646670A/en
Priority to IL34812A priority patent/IL34812A0/xx
Priority to AT583070A priority patent/AT300216B/de
Priority to NL7009760A priority patent/NL7009760A/xx
Priority to FR7024373A priority patent/FR2059467A1/fr
Priority to BE752866D priority patent/BE752866A/fr
Publication of DE1934272A1 publication Critical patent/DE1934272A1/de
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A61K31/567—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in position 17 alpha, e.g. mestranol, norethandrolone
    • A—HUMAN NECESSITIES
    • A47—FURNITURE; DOMESTIC ARTICLES OR APPLIANCES; COFFEE MILLS; SPICE MILLS; SUCTION CLEANERS IN GENERAL
    • A47J—KITCHEN EQUIPMENT; COFFEE MILLS; SPICE MILLS; APPARATUS FOR MAKING BEVERAGES
    • A47J41/00—Thermally-insulated vessels, e.g. flasks, jugs, jars
    • A47J41/02—Vacuum-jacket vessels, e.g. vacuum bottles
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Physics & Mathematics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Food Science & Technology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Thermal Sciences (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Steroid Compounds (AREA)
DE19691934272 1969-07-02 1969-07-02 d-18-Methyl-17 alpha-alkinyl-4-oestren-17 beta-ole Pending DE1934272A1 (de)

Priority Applications (8)

Application Number Priority Date Filing Date Title
DE19691934272 DE1934272A1 (de) 1969-07-02 1969-07-02 d-18-Methyl-17 alpha-alkinyl-4-oestren-17 beta-ole
ZA703801A ZA703801B (en) 1969-07-02 1970-06-04 D-18-methyl-17alpha-alkynyl-delta4-oestren-17beta-ols
AU16466/70A AU1646670A (en) 1969-07-02 1970-06-17 d-18-METHYL-17d-ALKYNYL-4-OESTREN-17b-OLS
IL34812A IL34812A0 (en) 1969-07-02 1970-06-28 D-18-methyl-17alpha-alkynyl delta4-oestren-17beta-ols
AT583070A AT300216B (de) 1969-07-02 1970-06-29 Verfahren zur Herstellung von neuen d-18-Methyl-17α-alkinyl-4-östren-17β-olen
NL7009760A NL7009760A (fr) 1969-07-02 1970-07-01
FR7024373A FR2059467A1 (fr) 1969-07-02 1970-07-01 Alcynyl-oestrenes et medicaments qui en contiennent
BE752866D BE752866A (fr) 1969-07-02 1970-07-02 D-18-methyl-17 alpha-alkynyl-4-oestren-17beta-ols et leur procede de preparation

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19691934272 DE1934272A1 (de) 1969-07-02 1969-07-02 d-18-Methyl-17 alpha-alkinyl-4-oestren-17 beta-ole

Publications (1)

Publication Number Publication Date
DE1934272A1 true DE1934272A1 (de) 1971-01-14

Family

ID=5739043

Family Applications (1)

Application Number Title Priority Date Filing Date
DE19691934272 Pending DE1934272A1 (de) 1969-07-02 1969-07-02 d-18-Methyl-17 alpha-alkinyl-4-oestren-17 beta-ole

Country Status (8)

Country Link
AT (1) AT300216B (fr)
AU (1) AU1646670A (fr)
BE (1) BE752866A (fr)
DE (1) DE1934272A1 (fr)
FR (1) FR2059467A1 (fr)
IL (1) IL34812A0 (fr)
NL (1) NL7009760A (fr)
ZA (1) ZA703801B (fr)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0017094A1 (fr) * 1979-03-30 1980-10-15 Schering Aktiengesellschaft 11-Méthylène stéroides, procédé pour leur préparation et préparations pharmaceutiques les contenant
EP0034114A1 (fr) * 1980-02-11 1981-08-19 Schering Aktiengesellschaft 3-Desoxy-delta 15-stéroides, procédé pour leur préparation et compositions pharmaceutiques les contenant

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0017094A1 (fr) * 1979-03-30 1980-10-15 Schering Aktiengesellschaft 11-Méthylène stéroides, procédé pour leur préparation et préparations pharmaceutiques les contenant
EP0034114A1 (fr) * 1980-02-11 1981-08-19 Schering Aktiengesellschaft 3-Desoxy-delta 15-stéroides, procédé pour leur préparation et compositions pharmaceutiques les contenant

Also Published As

Publication number Publication date
AU1646670A (en) 1971-12-23
AT300216B (de) 1972-07-25
FR2059467A1 (fr) 1971-06-04
IL34812A0 (en) 1970-08-19
ZA703801B (en) 1971-01-27
NL7009760A (fr) 1971-01-05
BE752866A (fr) 1971-01-04

Similar Documents

Publication Publication Date Title
CH619240A5 (fr)
DE1934272A1 (de) d-18-Methyl-17 alpha-alkinyl-4-oestren-17 beta-ole
DE1235316B (de) Verfahren zur Herstellung von 17alpha-AEthinyl-delta 1,3,5(10)-oestratrien-3, 16alpha17beta-triol sowie seiner Ester und AEther
DE1493165C3 (de) 1 -Hydroxyöstradiol-Derivate, Verfahren zu ihrer Herstellung sowie diese enthaltendes Mittel
CH498818A (de) Verfahren zur Herstellung von neuen 17a-Alka-1',3'-diinyl-17B-hydroxy-steroiden
DE1493161C3 (fr)
DE2207421C3 (de) 15α, 16α -Methylen-4-östren-17β -ole bzw. -acylate, Verfahren zu ihrer Herstellung sowie diese enthaltende Arzneimittel
DE1593509C3 (de) 1-Hydroxy-7alpha-methyl-östradlol-Derivate, Verfahren zu deren Herstellung sowie diese enthaltende Mittel
CH537913A (de) Verfahren zur Herstellung von 5(10)-Keto-19-nor-steroiden
DE2449327C2 (de) 7 α-Hydroxy-östradiole, Verfahren zu deren Herstellung und diese enthaltende Arzneimittel
DE1468988B1 (de) 17alpha-Chloraethinyl-13beta-aethyl-4- oder -5(10)-gonen-3-ketone
AT233177B (de) Verfahren zur Herstellung des neuen 6α-Methyl-17 α-hydroxyprogesterons und seiner Ester
DE2056512C3 (fr)
AT250579B (de) Verfahren zur Herstellung von neuen 3-Methylen-steroiden
DE3144049A1 (de) 16(beta)-methyl-8(alpha)-oestradiole, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische praeparate
DE1618980C3 (de) In 17-Stellung substituierte 11, 13beta-Dialkylgon-4-en-3,17beta-diole und deren Ester
DE870409C (de) Verfahren zur Herstellung von 3-Ketonen der Androstan- und der Pregnanreihe
AT231617B (de) Verfahren zur Herstellung von 4-Hydroxy- bzw 4-Acyloxy-17α-methyl-19-nortestosteron
AT275054B (de) Verfahren zur Herstellung von neuen 9β,10α-Steroiden
AT339514B (de) Verfahren zur herstellung von neuen 15alfa,16alfa-methylen-4-ostren-17beta-olen
AT270893B (de) Verfahren zur Herstellung von neuen 19-Alkenylsteroiden
AT270885B (de) Verfahren zur Herstellung von 17α-Halogenäthinyl-östra-4,9(10)-dien-3-onen
AT257060B (de) Verfahren zur Herstellung von neuen 3-Enoläthern der 6-Methyl-3-oxo-Δ<4>-steroide der Androstan-, 19-Norandrostan-, Pregnan- und 19-Norpregnanreihe
DE1493163C3 (de) nalpha-Äthinyl-ie-methyl-Delta hoch 4-östren-3 beta-17 betadiole, Verfahren zu deren Herstellung sowie diese enthaltende Mittel
DE1468988C (de) nalpha-Chloräthinyl-lSbeta-äthyl-4-oder-5( 10)- gonen-3 -ketone.'